SMART

SMART Study

Symptom Management versus Alternative Randomized Treatment of Concussion Trial

Study Summary

The SMART study is a randomized controlled trial addressing the need for early implementation of treatment approaches to concussed youth aged 13-19 years. This trial has multifaceted treatment approaches, specifically 3 arms of treatment: Headache, Dizziness/Neck Pain, Sleep. The purpose of this clinical trial is to examine which treatment option within the arm is most effective for post-concussion symptom relief.

Objectives

The objective of the SMART study is to examine if 6-week symptom specific treatments initiated in the acute/sub-acute stages (1-3 weeks) following concussion in 13–19-year-old participants recruited acutely
(<2 weeks) following concussion are superior to a multimodal 6-week treatment program.

Principal Study Investigators: Dr. Carolyn Emery and Dr. Keith Yeates

Leading Institution: University of Calgary

PERT Site Investigator: Dr. Antonia Stang

PERT Site Research Coordinator: Ashley Jones

Study Team: Dr. Carolyn Emery, Dr. Keith Yeates, Heather Godfrey, Astrid Han  

CIHR